[Federal Register Volume 86, Number 115 (Thursday, June 17, 2021)]
[Notices]
[Pages 32284-32285]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-12756]


=======================================================================
-----------------------------------------------------------------------

NATIONAL AERONAUTICS AND SPACE ADMINISTRATION

[Notice: (21-035)]


Notice of Intent To Grant an Exclusive, Co-Exclusive or Partially 
Exclusive Patent License

AGENCY: National Aeronautics and Space Administration.

ACTION: Notice of intent to grant exclusive, co-exclusive or partially 
exclusive patent license.

-----------------------------------------------------------------------

SUMMARY: NASA hereby gives notice of its intent to grant an exclusive, 
co-exclusive or partially exclusive patent license to practice the 
inventions described and claimed in the patents and/or patent 
applications listed in SUPPLEMENTARY INFORMATION below.

DATES: The prospective exclusive, co-exclusive or partially exclusive 
license may be granted unless NASA receives written objections 
including evidence and argument, no later than July 2, 2021 that 
establish that the grant of the license would not be consistent with 
the requirements regarding the licensing of federally owned inventions 
as set forth in the Bayh-Dole Act and implementing regulations. 
Competing applications completed and received by NASA no later than 
July 2, 2021 will also be treated as objections to the grant of the 
contemplated exclusive, co-exclusive or

[[Page 32285]]

partially exclusive license. Objections submitted in response to this 
notice will not be made available to the public for inspection and, to 
the extent permitted by law, will not be released under the Freedom of 
Information Act.

FOR FURTHER INFORMATION CONTACT: Written objections relating to the 
prospective license or requests for further information may be 
submitted to Agency Counsel for Intellectual Property, NASA 
Headquarters at Email: <a href="/cdn-cgi/l/email-protection#036b722e736277666d776c65656a6066436e626a6f2d6d6270622d646c75"><span class="__cf_email__" data-cfemail="375f461a4756435259435851515e5452775a565e5b195956445619505841">[email protected]</span></a>. Questions may be 
directed to Helen Galus at (202) 358-3437.

SUPPLEMENTARY INFORMATION: NASA intends to grant an exclusive, co-
exclusive, or partially exclusive patent license in the United States 
to practice the inventions described and claimed in: US 8,735,116 B2, 
High-Density Spot Seeding for Tissue Model Formation and US 9,243,223 
B2, High-Density Spot Seeding for Tissue Model Formation to BSK Health 
Partners, LLC. having its principal place of business in North Richland 
Hills, Texas. The fields of use may be limited. NASA has not yet made a 
final determination to grant the requested license and may deny the 
requested license even if no objections are submitted within the 
comment period.
    This notice of intent to grant an exclusive, co-exclusive or 
partially exclusive patent license is issued in accordance with 35 
U.S.C. 209(e) and 37 CFR 404.7(a)(1)(i). The patent rights in these 
inventions have been assigned to the United States of America as 
represented by the Administrator of the National Aeronautics and Space 
Administration. The prospective license will comply with the 
requirements of 35 U.S.C. 209 and 37 CFR 404.7.
    Information about other NASA inventions available for licensing can 
be found online at http://technology.nasa.gov.

Helen M. Galus,
Agency Counsel for Intellectual Property.
[FR Doc. 2021-12756 Filed 6-16-21; 8:45 am]
BILLING CODE 7510-13-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>